A retired journalist who took part in the clinical trial for the new Alzheimer’s drug has described how he feels “as normal ...
Donanemab works by removing a sticky protein called beta-amyloid from the brain that is believed to cause Alzheimer's disease, and in the trials ...
Eli Lilly (LLY) announced that the Medicines and Healthcare products Regulatory Agency, or MHRA, has granted marketing authorization for ...